I couldn't remember the name of something, for an email - you know who you are
And I found this, just for a change of speed today.
From https://www.bloomberg.com/press-releases/2021-02-10/takeda-submits-new-drug-application-to-manufacture-and-market-darvadstrocel-in-japan-for-treatment-of-complex-perianal-fistulas
This would be under license to Mesoblast as it is in the EU. Oh, and notice "for the Company’s First Allogeneic Stem Cell
Therapy in Japan" The other product in Japan is Temcell made by JCR Pharmaceuticals, under license to Mesoblast.
Cell Therapy News/Articles, page-8407
-
- There are more pages in this discussion • 9,623 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.070(6.57%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | 99.5¢ | $3.980M | 3.944M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 56239 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 103125 | 2 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |